Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Change in Cash (2021 - 2025)

Cardio Diagnostics Holdings' Change in Cash history spans 5 years, with the latest figure at -$1.6 million for Q3 2025.

  • For Q3 2025, Change in Cash fell 339.61% year-over-year to -$1.6 million; the TTM value through Sep 2025 reached $4.4 million, up 365.48%, while the annual FY2024 figure was $6.5 million, 330.91% up from the prior year.
  • Change in Cash for Q3 2025 was -$1.6 million at Cardio Diagnostics Holdings, up from -$1.7 million in the prior quarter.
  • Across five years, Change in Cash topped out at $9.3 million in Q2 2022 and bottomed at -$4.8 million in Q4 2022.
  • The 5-year median for Change in Cash is -$96422.5 (2021), against an average of $356278.2.
  • The largest YoY upside for Change in Cash was 27198.64% in 2022 against a maximum downside of 7289.53% in 2022.
  • A 5-year view of Change in Cash shows it stood at $526625.0 in 2021, then tumbled by 1020.29% to -$4.8 million in 2022, then surged by 51.59% to -$2.3 million in 2023, then skyrocketed by 349.13% to $5.8 million in 2024, then plummeted by 127.57% to -$1.6 million in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Change in Cash are -$1.6 million (Q3 2025), -$1.7 million (Q2 2025), and $1.9 million (Q1 2025).